Caution in Expanding the Use of Abbreviated R-CHOP to Poor-Risk Limited-Stage DLBCL

Affiliation

• ¹ Eliza A. Hawkes, MBBS, DMedSc, Department of Clinical Haematology and Medical Oncology, Olivia Newton-John Cancer Research Institute at Austin Health, Heidelberg, Victoria, Australia; Stephen Opat, MBBS, Clinical Haematology, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia; and Mark Hertzberg, MBBS, PhD, Department of Haematology, Prince of Wales Hospital and University of New South Wales, Randwick, New South Wales, Australia.